Prophylactic percutaneous endoscopic gastrostomy in patients with head and neck cancer: Influence on nutritional status, utilisation rate and complications.
Journal
International journal of clinical practice
ISSN: 1742-1241
Titre abrégé: Int J Clin Pract
Pays: India
ID NLM: 9712381
Informations de publication
Date de publication:
Nov 2019
Nov 2019
Historique:
received:
08
05
2019
revised:
30
07
2019
accepted:
08
08
2019
pubmed:
14
8
2019
medline:
8
1
2020
entrez:
14
8
2019
Statut:
ppublish
Résumé
Patients with head and neck cancer (HNC) are at high risk for malnutrition because of tumour localisation and therapy. Prophylactic percutaneous endoscopic gastrostomy (PEG) tube placement is common practice to prevent malnutrition. To investigate the benefits of prophylactic PEG tube placement for HNC patients in terms of the influence on patients' nutritional status, utilisation rate, complications and to identify the predictors of PEG tube utilisation. All consecutive HNC patients who underwent prophylactic PEG tube insertion between 1 January 2011 and 31 December 2012 prior to therapy were enrolled. The PEG tube utilisation rate, complications, the patients' nutritional status and tumour therapy were evaluated with the help of electronic patient charts and telephone interviews. A total of 181 patients (48 female, median 67.5 years) were included. The PEG utilisation rate in the entire cohort was 91.7%. One hundred and forty-nine patients (82.3%) used the PEG tube for total enteral nutrition, 17 patients (9.4%) for supplemental nutrition and 15 patients (8.3%) made no use of the PEG tube. Peristomal wound infections were the most common complications (40.3%) in this study. A high Nutritional Risk Screening (NRS) score prior to tube insertion was found to be independently associated with PEG utilisation. No significant weight changes were observed across the three patient subgroups. The overall PEG tube utilisation rate was high in this study. However, given the high rate of infections, diligent patient selection is crucial in order to determine which patients benefit most from prophylactic PEG tube insertion.
Sections du résumé
BACKGROUND
BACKGROUND
Patients with head and neck cancer (HNC) are at high risk for malnutrition because of tumour localisation and therapy. Prophylactic percutaneous endoscopic gastrostomy (PEG) tube placement is common practice to prevent malnutrition.
OBJECTIVE
OBJECTIVE
To investigate the benefits of prophylactic PEG tube placement for HNC patients in terms of the influence on patients' nutritional status, utilisation rate, complications and to identify the predictors of PEG tube utilisation.
METHODS
METHODS
All consecutive HNC patients who underwent prophylactic PEG tube insertion between 1 January 2011 and 31 December 2012 prior to therapy were enrolled. The PEG tube utilisation rate, complications, the patients' nutritional status and tumour therapy were evaluated with the help of electronic patient charts and telephone interviews.
RESULTS
RESULTS
A total of 181 patients (48 female, median 67.5 years) were included. The PEG utilisation rate in the entire cohort was 91.7%. One hundred and forty-nine patients (82.3%) used the PEG tube for total enteral nutrition, 17 patients (9.4%) for supplemental nutrition and 15 patients (8.3%) made no use of the PEG tube. Peristomal wound infections were the most common complications (40.3%) in this study. A high Nutritional Risk Screening (NRS) score prior to tube insertion was found to be independently associated with PEG utilisation. No significant weight changes were observed across the three patient subgroups.
CONCLUSIONS
CONCLUSIONS
The overall PEG tube utilisation rate was high in this study. However, given the high rate of infections, diligent patient selection is crucial in order to determine which patients benefit most from prophylactic PEG tube insertion.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13405Informations de copyright
© 2019 The Authors. International Journal of Clinical Practice published by John Wiley & Sons Ltd.
Références
Forastiere AA, Zhang Q, Weber RS, et al. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol. 2013;31:845-852. https://doi.org/10.1200/JCO.2012.43.6097
Bradley PT, Brown T, Paleri V. Gastrostomy in head and neck cancer: current literature, controversies and research. Curr Opin Otolaryngol Head Neck Surg. 2015;23:162-170. https://doi.org/10.1097/MOO.0000000000000135
Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus Cetuximab for Squamous cell carcinoma of the head and neck. N Eng J Med. 2006;354:567-578. https://doi.org/10.1056/NEJMoa053422
Christianen M, Verdonck-de Leeuw IM, Doornaert P, et al. Patterns of long-term swallowing dysfunction after definitive radiotherapy or chemoradiation. Radiother Oncol. 2015;117(1):139-144.https://doi.org/10.1016/j.radonc.2015.07.042.
Van Der Laan B, Van Der Laan HP, Bijl HP, et al. Acute symptoms during the course of head and neck radiotherapy or chemoradiation are strong predictors of late dysphagia. Radiother Oncol. 2015;115:56-62. https://doi.org/10.1016/j.radonc.2015.01.019
Bruixola G, Caballero J, Papaccio F, et al. Prognostic nutritional index as an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer. ESMO Open. 2018;3:e000425. https://doi.org/10.1136/esmoopen-2018-000425.
Bossi P. Prognostic nutritional index: an easy nutritional screening for patients with head and neck cancer? ESMO Open. 2018;3:e000449. https://doi.org/10.1136/esmoopen-2018-000449
Bharadwaj S, Ginoya S, Tandon P, et al. Malnutrition: laboratory markers vs nutritional assessment. Gastroenterol Rep (Oxf). 2016;4:272-280.
Capuano G, Grosso A, Gentile PC, et al. Influence of weight loss on outcomes in patients with head and neck cancer undergoing concomitant chemoradiotherapy. Head Neck. 2008;30:503-508. https://doi.org/10.1002/hed.20737
Marín Caro MM, Laviano A, Pichard C. Nutritional intervention and quality of life in adult oncology patients. Clin Nutr. 2007;26:289-301. https://doi.org/10.1016/j.clnu.2007.01.005
Sinicrope FA, Foster NR, Yothers G, et al. Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy. Cancer. 2013;119:1528-1536. https://doi.org/10.1002/cncr.27938
Büntzel J, Micke O, Kisters K, Büntzel J, Mücke R. Malnutrition and survival-bioimpedance data in head neck cancer patients. In Vivo (Brooklyn). 2019;33:979-982.
Arends J, Bodoky G, Bozzetti F, et al. ESPEN guidelines on enteral nutrition: non-surgical oncology. Clin Nutr. 2006;25(2):245-259. https://doi.org/10.1016/j.clnu.2006.01.020
Bankhead R, Boullata J, Brantley S, et al. Enteral nutrition practice recommendations. J Parenter Enter Nutr. 2009;33:122-167. https://doi.org/10.1177/0148607108330314
Valentini L, Volkert D, Schütz T, et al. Leitlinie der Deutschen Gesellschaft für Ernährungsmedizin (DGEM). Aktuel Ernahrungsmed. 2013;38:97-111. https://doi.org/10.1055/s-0032-1332980
Cady J. Nutritional support during radiotherapy for head and neck cancer: the role of prophylactic feeding tube placement. Clin J Oncol Nurs. 2007;11:875-880. https://doi.org/10.1188/07.CJON.875-880
Locher JL, Bonner JA, Carroll WR, et al. Patterns of prophylactic gastrostomy tube placement in head and neck cancer patients: a consideration of the significance of social support and practice variation. Laryngoscope. 2013;123:1918-1925. https://doi.org/10.1002/lary.24022
Martin Villares C, San Roman Carbajo J. Fernandez Pello ME, Tapia Risueno M, Dominguez Calvo J [Nutritional status in head and neck cancer patients: the impact on the prognoses]. El Estado Nutr en Pacientes con Cancer Cabeza y Cuello Implicaciones Pronost. 2003;18:91-94.
Kramer S, Newcomb M, Hessler J, Siddiqui F. Prophylactic versus reactive PEG tube placement in head and neck cancer. Otolaryngol-Head Neck Surg (United States). 2014;150:407-412. https://doi.org/10.1177/0194599813517081
Beer KT, Krause KB, Zuercher T, Stanga Z. Early percutaneous endoscopic gastrostomy insertion maintains nutritional state in patients with aerodigestive tract cancer. Nutr Cancer. 2005;52:29-34. https://doi.org/10.1207/s15327914nc5201_4
Nguyen NP, North D, Smith HJ, et al. Safety and effectiveness of prophylactic gastrostomy tubes for head and neck cancer patients undergoing chemoradiation. Surg Oncol. 2006;15(4):199-203. https://doi.org/10.1016/j.suronc.2006.12.002
Blumenstein I, Shastri YM, Stein J. Gastroenteric tube feeding: techniques, problems and solutions. World J Gastroenterol. 2014;20:8505. https://doi.org/10.3748/wjg.v20.i26.8505
Jain R, Maple JT, Anderson MA, et al. The role of endoscopy in enteral feeding. Gastrointest Endosc. 2011;74:7-12. https://doi.org/10.1016/j.gie.2010.10.021
Blomberg J, Lagergren J, Martin L, Mattsson F, Lagergren P. Complications after percutaneous endoscopic gastrostomy in a prospective study. Scand J Gastroenterol. 2012;47:737-742. https://doi.org/10.3109/00365521.2012.654404
Peveling-Oberhag J, Osman I, Walter D, et al. Risk factors for early and late procedure-related adverse events in percutaneous endoscopic gastrostomy: a single center, retrospective study. J Gastroenterol Hepatol. 2019;34(2):404-409.
Löser C, Aschl G, Hébuterne X, et al. ESPEN guidelines on artificial enteral nutrition - Percutaneous endoscopic gastrostomy (PEG). Clin Nutr. 2005;24:848-861. https://doi.org/10.1016/j.clnu.2005.06.013
McAllister P, MacIver C, Wales C, et al. Gastrostomy insertion in head and neck cancer patients: a 3 year review of insertion method and complication rates. Br J Oral Maxillofac Surg. 2013;51(8):714-718. https://doi.org/10.1016/j.bjoms.2013.07.005
Locher JL, Bonner JA, Carroll WR, et al. Prophylactic percutaneous endoscopic gastrostomy tube placement in treatment of head and neck cancer: a comprehensive review and call for evidence-based medicine. J Parenter Enter Nutr. 2011;35:365-374. https://doi.org/10.1177/0148607110377097
Kyle UG, Kossovsky MP, Karsegard VL, Pichard C. Comparison of tools for nutritional assessment and screening at hospital admission: a population study. Clin Nutr. 2006;25:409-417. https://doi.org/10.1016/j.clnu.2005.11.001
Kondrup J, Allison SP, Elia M, Vellas B, Plauth M. ESPEN guidelines for nutrition screening 2002. Clin Nutr. 2003;22:415-421. https://doi.org/10.1016/S0261-5614(03)00098-0
Rahnemai-Azar AA, Rahnemaiazar AA, Naghshizadian R, Kurtz A, Farkas DT. Percutaneous endoscopic gastrostomy: indications, technique, complications and management. World J Gastroenterol. 2014;20:7739. https://doi.org/10.3748/wjg.v20.i24.7739
Cardella JF, Kundu S, Miller DL, Millward SF, Sacks D. Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol. 2009;20:S189-S191. https://doi.org/10.1016/j.jvir.2009.04.035
Danan D, Shonka DC, Selman Y, Chow Z, Smolkin ME, Jameson MJ. Prognostic value of albumin in patients with head and neck cancer. Laryngoscope. 2016;126(7):1567-1571. https://doi.org/10.1002/lary.25877
Mangar S, Slevin N, Mais K, Sykes A. Evaluating predictive factors for determining enteral nutrition in patients receiving radical radiotherapy for head and neck cancer: a retrospective review. Radiother Oncol. 2006;78:152-158. https://doi.org/10.1016/j.radonc.2005.12.014
Pulkkinen J, Rekola J, Asanti M, Grénman R. Prophylactic percutaneous endoscopic gastrostomy in head and neck cancer patients: results of tertiary institute. Eur Arch Oto-Rhino-Laryngology. 2014;271:1755-1758. https://doi.org/10.1007/s00405-013-2699-2
Kaderbay A, Atallah I, Fontaine E, et al. Malnutrition and refeeding syndrome prevention in head and neck cancer patients: from theory to clinical application. Eur Arch Oto-Rhino-Laryngology. 2018;275:1049-1058. https://doi.org/10.1007/s00405-018-4935-2
Madhoun MF, Blankenship MM, Blankenship DM, Krempl GA, Tierney WM. Prophylactic peg placement in head and neck cancer: how many feeding tubes are unused (and unnecessary)? World J Gastroenterol. 2011;17:1004. https://doi.org/10.3748/wjg.v17.i8.1004
Johnston SD, Tham T, Mason M. Death after PEG: results of the national confidential enquiry into patient outcome and death. Gastrointest Endosc. 2008;68:223-227. https://doi.org/10.1016/j.gie.2007.10.019
Williams GF, Teo M, Sen M, Dyker KE, Coyle C, Prestwich R. Enteral feeding outcomes after chemoradiotherapy for oropharynx cancer: a role for a prophylactic gastrostomy? Oral Oncol. 2012;48:434-440. https://doi.org/10.1016/j.oraloncology.2011.11.022
Oozeer NB, Corsar K, Glore RJ, Penney S, Patterson J, Paleri V. The impact of enteral feeding route on patient-reported long term swallowing outcome after chemoradiation for head and neck cancer. Oral Oncol. 2011;47:980-983. https://doi.org/10.1016/j.oraloncology.2011.07.011
Axelsson L, Silander E, Nyman J, Bove M, Johansson L, Hammerlid E. Effect of prophylactic percutaneous endoscopic gastrostomy tube on swallowing in advanced head and neck cancer: a randomized controlled study. Head Neck. 2017;39:908-915. https://doi.org/10.1002/hed.24707
Koyfman SA, Adelstein DJ. Enteral feeding tubes in patients undergoing definitive chemoradiation therapy for head-and-neck cancer: a critical review. Int J Radiat Oncol Biol Phys. 2012;84:581-589. https://doi.org/10.1016/j.ijrobp.2012.03.053
Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008;26:3582-3589. https://doi.org/10.1200/JCO.2007.14.8841
Cheng SS, Terrell JE, Bradford CR, et al. Variables associated with feeding tube placement in head and neck cancer. Arch Otolaryngol-Head Neck Surg. 2006;132:655-661. https://doi.org/10.1001/archotol.
Karsten RT, Stuiver MM, van der Molen L, et al. From reactive to proactive tube feeding during chemoradiotherapy for head and neck cancer: a clinical prediction model- based approach. Oral Oncol. 2019;88:172-179.
Jack DR, Dawson FR, Reilly JE, Shoaib T. Guideline for prophylactic feeding tube insertion in patients undergoing resection of head and neck cancers. J Plast Reconstr Aesthetic Surg. 2012;65:610-615. https://doi.org/10.1016/j.bjps.2011.11.018
Frenkel CH, Yang J, Zhang M, Ferrara A, Telem DA, Samara GJ. Gastrostomy in the era of minimally invasive head and neck cancer surgery. Laryngoscope. 2018;128:847-851. https://doi.org/10.1002/lary.26829
Ermis F, Ozel M, Oncu K, et al. Indications, complications and long-term follow-up of patients undergoing percutaneous endoscopic gastrostomy: a retrospective study. Wien Klin Wochenschr. 2012;124:148-153. https://doi.org/10.1007/s00508-011-0082-0
Schneider AS, Schettler A, Markowski A, et al. Complication and mortality rate after percutaneous endoscopic gastrostomy are low and indication-dependent. Scand J Gastroenterol. 2014;49:891-898. https://doi.org/10.3109/00365521.2014.916343
Vanis N, Saray A, Gornjakovic S, Mesihovic R. Percutaneous endoscopic gastrostomy (PEG): retrospective analysis of a 7-year clinical experience. Acta Inf Med. 2012;20:235-237.
Preclik G, Grune S, Leser HG, et al. Prospective, randomised, double blind trial of prophylaxis with single dose of co-amoxiclav before percutaneous endoscopic gastrostomy. BMJ. 1999;319:881-881. https://doi.org/10.1136/bmj.319.7214.881